Huanbian Taozhi Jiaonang (环扁桃酯胶囊)环扁桃酯胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山西仟源医药集团股份有限公司Chinese legal name: 山西仟源医药集团股份有限公司
主要成分Active Ingredients
- 环扁桃酯Huanbian Taozhi
药物知识说明
环扁桃酯是一种在国家药监局注册认定的药品。该药品含有环扁桃酯-bafd00f4等成分。
该药品关联的活性成分包括：环扁桃酯Huanbian Taozhi。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：山西仟源医药集团股份有限公司Chinese legal name: 山西仟源医药集团股份有限公司。
您可以探索含有相同成分的其他药品：环扁桃酯-bafd00f4成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 环扁桃酯胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 环扁桃酯Huanbian Taozhi.
Manufacturers recorded for this product: 山西仟源医药集团股份有限公司Chinese legal name: 山西仟源医药集团股份有限公司.
Explore other medicines containing the same ingredient: 环扁桃酯 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 环扁桃酯胶囊Recorded Chinese name: 环扁桃酯胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.1g0.1 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 山西仟源医药集团股份有限公司Chinese legal name: 山西仟源医药集团股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H14023561
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H14023561
Manufacturer
Chinese legal name: 山西仟源医药集团股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H14023561
生产企业
山西仟源医药集团股份有限公司(国产)
适应症
本品用于缺血性脑血管疾病、脑动脉硬化症、脑外伤后遗症、肢端动脉痉挛症、手足发绀、闭塞性动脉内膜炎、内耳眩晕症等。
用法用量
1.口服给药： 800～1200mg/日。一次100～200mg，一日3～4次。|2.症状改善后可减量至一日300～400mg。|3.脑血管疾病一般每次服200～400mg，一日3次。
不良反应
可引起恶心、呕吐、食欲不振、上腹部不适，有时面部潮红、眩晕、头痛、皮疹、瘙痒症、口干、心悸、低血压、麻木感、震颤、心动过速、出汗等。
禁忌
脑血管意外重症急性期、孕妇及哺乳期妇女禁用。
注意事项
严重闭塞性冠状动脉和脑血管疾病、青光眼、出血或有出血倾向的患者慎用。
贮藏
遮光，密封保存。
规格
0.1g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.